Introduction of mutations in insulin molecule: positive and negative mutations

   
Ksenofontova O.I.1

1. Saint Petersburg State University, Department of Biology
Section: Review
DOI: 10.18097/pbmc20146004430      UDK: 577.171.7      PubMed Id: 25249526
Year: 2014  Volume: 60  Issue: 4  Pages: 430-437
Introduction of mutations in an insulin molecule is one of the important approaches to drug development for treatment of diabetes mellitus. Generally, usage of mutations is aimed at activation of insulin and insulin receptor interaction. Such mutations can be considered as positive. Mutations that reduce the binding efficacy are negative. There are neutral mutations as well. This article considers both natural mutations that are typical for various members of the insulin superfamily and artificial ones which are introduced to improve the insulin pharmacological characteristics. Data presented here can be useful in developing new effective insulin analogues for treatment of diabetes mellitus.
Download PDF:
Reference:

Ksenofontova O.I. (2014) Biomeditsinskaya khimiya, 60(4), 430-437.
This paper is also available as the English translation:10.1134/S1990750813040045
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)
        

© Institute of Biomedical Chemistry, Moscow, Russia